Evaluation of sub-acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer
Open Access
- 19 May 2009
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 100 (12) , 1861-1866
Abstract
Long-term cardiovascular morbidity is increasingly observed in chemotherapy-treated testicular cancer survivors, but little is known of early sub-clinical changes in cardiac function. We prospectively evaluated cardiac function in testicular cancer patients by echocardiography. Systolic (Wall Motion Score Index) and diastolic (E/A-ratio and Tissue Velocity Imaging (TVI)) parameters, and serum levels of N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP) were assessed before the start of chemotherapy and 1 year later. Echocardiography data were compared with an age-matched group of healthy controls. Forty-two patients treated with bleomycin, etoposide and cisplatin were evaluated (median age 27 years, range 18–50). Systolic function and E/A-ratio did not change, whereas the median TVI decreased (12.0 vs 10.0 cms−1; P=0.002). Median levels of NT-proBNP increased (5 vs 18 pmoll−1, P=0.034). Compared with controls, TVI before the start of chemotherapy was not significantly different. In conclusion, we found that at a median of 10 months after cisplatin-based treatment for testicular cancer, TVI decreased significantly, indicating a deterioration of diastolic cardiac function. Serum levels of NT-proBNP increased. The prognostic significance of these changes for future cardiovascular morbidity is not clear.Keywords
This publication has 27 references indexed in Scilit:
- Left Ventricular Ejection Fraction and Cardiotoxicity: Is Our Ear Really to the Ground?Journal of Clinical Oncology, 2008
- Age‐Dependency of Classic and New Parameters of Diastolic FunctionEchocardiography, 2007
- N-Terminal-proB-Type Natriuretic Peptide as a Marker for Acute Anthracycline Cardiotoxicity in ChildrenJournal of Pediatric Hematology/Oncology, 2007
- How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of CardiologyEuropean Heart Journal, 2007
- Components of the metabolic syndrome in long-term survivors of testicular cancerAnnals of Oncology, 2006
- Long-term cardiac follow-up in survivors of a malignant bone tumourAnnals of Oncology, 2006
- Acute Chemotherapy-Induced Cardiovascular Changes in Patients With Testicular CancerJournal of Clinical Oncology, 2005
- The Metabolic Syndrome and Disturbances in Hormone Levels in Long-Term Survivors of Disseminated Testicular CancerJournal of Clinical Oncology, 2005
- Application of Tissue Doppler Imaging in CardiologyCardiology, 2004
- ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article*1A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to update the 1997 guidelines for the clinical application of echocardiography)Journal of the American Society of Echocardiography, 2003